Saisheng Pharmaceutical (6600.HK) 2022 Annual Results Conference
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.
Read more
Comment
Sign in to view/post comments
賽生藥業官方賬號
An international biopharmaceutical company with excellent commercialization capabilities and differentiated innovative pipelines, two-wheel drive, focusing on the fields of oncology and severe infections
77KFollowers
13KVisitors
Follow